Vistagen Therapeutics, Inc. earnings per share and revenue

VTGN earnings per share for the last quarter are -0.46 USD whereas the estimation was -0.51 USD which accounts for 9.75% surprise. Company revenue for the same period amounts to 234.00 k USD despite the estimated figure of 308.50 k USD. Estimated earnings per share for the next quarter are -0.51 USD, and revenue is expected to reach 313.75 k USD. Also watch annual changes over time to get a bigger picture of VTGN earnings per share and revenue dynamics.